Home Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

FPG #8: Alternative Treatments in Psychiatry
FPG #7: Critical Care in Neurology

Free Medical Books

  Leukemia

  Free Subscription


Articles published in Am J Hematol

Retrieve available abstracts of 101 articles:
HTML format
Text format



Single Articles


    January 2012
  1. ESTEY EH
    Acute myeloid leukemia: 2012 update on diagnosis, risk stratification, and management.
    Am J Hematol. 2012;87:89-99.
    PubMed     Text format     Related articles    Abstract available



    December 2011
  2. MORI T , Aisa Y, Kato J, Yamane A, et al
    Safety and efficacy of total body irradiation, cyclophosphamide, and cytarabine as a conditioning regimen for allogeneic hematopoietic stem cell transplantation in patients with acute lymphoblastic leukemia.
    Am J Hematol. 2011 Dec 29. doi: 10.1002/ajh.23109.
    PubMed     Text format     Related articles    Abstract available



  3. SAINI L , Minden MD, Schuh AC, Yee KW, et al
    Feasibility of outpatient consolidation chemotherapy in older versus younger patients with acute myeloid leukemia.
    Am J Hematol. 2011 Dec 3. doi: 10.1002/ajh.22268.
    PubMed     Text format     Related articles   



  4. RUMI E , Harutyunyan A, Elena C, Pietra D, et al
    Identification of genomic aberrations associated with disease transformation by means of high-resolution SNP array analysis in patients with myeloproliferative neoplasm.
    Am J Hematol. 2011;86:974-9.
    PubMed     Text format     Related articles    Abstract available



  5. LEE EY , Leung AY, Anthony MP, Loong F, et al
    Utility of 18F-FDG PET/CT in identifying terminal ileal myeloid sarcoma in an asymptomatic patient.
    Am J Hematol. 2011;86:1036-7.
    PubMed     Text format     Related articles   



    November 2011
  6. EGHTEDAR A , Borthakur G, Ravandi F, Jabbour E, et al
    Characteristics of translocation (16;16)(p13;q22) acute myeloid leukemia.
    Am J Hematol. 2011 Nov 23. doi: 10.1002/ajh.22258.
    PubMed     Text format     Related articles   



  7. CUNNINGHAM I
    A basis for updating our approach to resistant acute leukemia.
    Am J Hematol. 2011 Nov 16. doi: 10.1002/ajh.22256.
    PubMed     Text format     Related articles    Abstract available



    October 2011
  8. RACIL Z , Toskova M, Dvorakova D, Jeziskova I, et al
    Treatment of molecular relapse in patients with acute myeloid leukemia using clofarabine monotherapy.
    Am J Hematol. 2011 Oct 12. doi: 10.1002/ajh.22213.
    PubMed     Text format     Related articles   



    September 2011
  9. FARHAT H , Reman O, Raffoux E, Berthon C, et al
    Fractionated doses of gemtuzumab ozogamicin with escalated doses of daunorubicin and cytarabine as first acute myeloid leukemia salvage in patients aged 50-70-year old: A phase 1/2 study of the acute leukemia French association.
    Am J Hematol. 2011 Sep 26. doi: 10.1002/ajh.22201.
    PubMed     Text format     Related articles    Abstract available



  10. FANG B , Liu Y, Zhou J, Li Y, et al
    Salvage therapy with endostatin, low-dose homoharringtonine, and cytarabine in combination with granulocyte-colony stimulating factor for elderly patients with primary refractory acute myeloid leukemia.
    Am J Hematol. 2011 Sep 26. doi: 10.1002/ajh.22199.
    PubMed     Text format     Related articles   



  11. GHANEM H , Tank N, Tabbara IA
    Prognostic implications of genetic aberrations in acute myelogenous leukemia with normal cytogenetics.
    Am J Hematol. 2011 Sep 22. doi: 10.1002/ajh.22197.
    PubMed     Text format     Related articles    Abstract available



  12. BERMUDEZ A , Perez-Vazquez G, Insunza A, Baro J, et al
    FLAGIDA-lite is an effective regimen for patients between 70 and 80 years with acute myeloid leukemia or refractory anemia with excess blasts-2 and is feasible as outpatient treatment.
    Am J Hematol. 2011 Sep 21. doi: 10.1002/ajh.22192.
    PubMed     Text format     Related articles    Abstract available



  13. MEDEIROS BC , Kohrt HE, Gotlib J, Coutre SE, et al
    Tailored temozolomide therapy according to MGMT methylation status for elderly patients with acute myeloid leukemia.
    Am J Hematol. 2011 Sep 21. doi: 10.1002/ajh.22191.
    PubMed     Text format     Related articles    Abstract available



  14. AHN HK , Jang JH, Kim K, Kim HJ, et al
    Monosomal karyotype in acute myeloid leukemia predicts adverse treatment outcome and associates with high functional multidrug resistance activity.
    Am J Hematol. 2011 Sep 21. doi: 10.1002/ajh.22193.
    PubMed     Text format     Related articles    Abstract available



  15. TODESCHINI G , Bonifacio M, Tecchio C, Balter R, et al
    Intensive short-term chemotherapy regimen induces high remission rate (over 90%) and event-free survival both in children and adult patients with advanced sporadic Burkitt lymphoma/leukemia.
    Am J Hematol. 2011 Sep 13. doi: 10.1002/ajh.22189.
    PubMed     Text format     Related articles    Abstract available



  16. MUGHAL TI , Radich JP, Van Etten RA, Quintas-Cardama A, et al
    Chronic myeloid leukemia 2011: Successes, challenges, and strategies-Proceedings of the 5th annual BCR-ABL1 positive and BCR-ABL1 negative myeloproliferative neoplasms workshop.
    Am J Hematol. 2011;86:811-9.
    PubMed     Text format     Related articles   



  17. RACIL Z , Buresova L, Brejcha M, Prochazkova J, et al
    Clinical and laboratory features of leukemias at the time of diagnosis: an analysis of 1,004 consecutive patients.
    Am J Hematol. 2011;86:800-3.
    PubMed     Text format     Related articles   



    August 2011
  18. LAURENTI L , Tarnani M, Nichele I, Ciolli S, et al
    The coexistence of chronic lymphocytic leukemia and myeloproliperative neoplasms: A retrospective multicentric GIMEMA experience.
    Am J Hematol. 2011 Aug 22. doi: 10.1002/ajh.22171.
    PubMed     Text format     Related articles    Abstract available



  19. LEV S , Andrei B, Osnat B, Naomi RL, et al
    Survival trends among 1,325 patients with chronic lymphocytic leukemia seen over the past 40 years in Israel.
    Am J Hematol. 2011 Aug 4. doi: 10.1002/ajh.22160.
    PubMed     Text format     Related articles    Abstract available



  20. ELIA L , Grammatico S, Paoloni F, Vignetti M, et al
    Clinical outcome and monitoring of minimal residual disease in patients with acute lymphoblastic leukemia expressing the MLL/ENL fusion gene.
    Am J Hematol. 2011 Aug 4. doi: 10.1002/ajh.22161.
    PubMed     Text format     Related articles    Abstract available



  21. GAFTER-GVILI A , Leader A, Gurion R, Vidal L, et al
    High-dose imatinib for newly diagnosed chronic phase chronic myeloid leukemia patients-Systematic review and meta-analysis.
    Am J Hematol. 2011;86:657-62.
    PubMed     Text format     Related articles    Abstract available



  22. SWORDS RT , Dezube BJ, Medeiros BC
    Personalized medicine for acute myelogenous leukemia-At the entrance gate.
    Am J Hematol. 2011;86:631-2.
    PubMed     Text format     Related articles   



  23. LAZAREVIC VLJ , Remberger M, Hagglund H, Hallbook H, et al
    Myeloablative allogeneic stem cell transplantation for lymphoblastic lymphoma in Sweden: A retrospective study.
    Am J Hematol. 2011;86:709-10.
    PubMed     Text format     Related articles   



  24. BAIN BJ
    Auer rods or McCrae rods?
    Am J Hematol. 2011;86:689.
    PubMed     Text format     Related articles   



  25. THOENNISSEN NH , Lasho T, Thoennissen GB, Ogawa S, et al
    Novel CUX1 missense mutation in association with 7q- at leukemic transformation of MPN.
    Am J Hematol. 2011;86:703-5.
    PubMed     Text format     Related articles   



    July 2011
  26. INNES A , May PC, Pavlu J, Bain BJ, et al
    Unexpected pancytopenia following treatment of acute lymphoblastic leukemia.
    Am J Hematol. 2011 Jul 29. doi: 10.1002/ajh.22159.
    PubMed     Text format     Related articles   



  27. WOOD SM , Meyers CA, Faderl S, Kantarjian HM, et al
    Association of anemia and cognitive dysfunction in patients with acute myelogenous leukemia and myelodysplastic syndrome.
    Am J Hematol. 2011 Jul 25. doi: 10.1002/ajh.22151.
    PubMed     Text format     Related articles   



  28. ATANACKOVIC D , Luetkens T, Kloth B, Fuchs G, et al
    Cancer-testis antigen expression and its epigenetic modulation in acute myeloid leukemia.
    Am J Hematol. 2011 Jul 19. doi: 10.1002/ajh.22141.
    PubMed     Text format     Related articles    Abstract available



  29. WUDHIKARN K , Silverman M
    Fatal disseminated intravascular coagulation in acute promyelocytic leukemia.
    Am J Hematol. 2011 Jul 19. doi: 10.1002/ajh.22140.
    PubMed     Text format     Related articles   



  30. AL-SHIEBAN S , Liu C, Fishlock K, May PC, et al
    Bone marrow trephine biopsy findings in acute promyelocytic leukemia.
    Am J Hematol. 2011 Jul 14. doi: 10.1002/ajh.22127.
    PubMed     Text format     Related articles   



  31. JACOB E , Ranger A, Sohal M, Bain BJ, et al
    An uncommon morphological variant of acute promyelocytic leukemia.
    Am J Hematol. 2011 Jul 14. doi: 10.1002/ajh.22129.
    PubMed     Text format     Related articles   



  32. SINGH H , Werner LL, Asali S, Deangelo DJ, et al
    Comparison of autologous stem cell transplantation versus consolidation chemotherapy for patients with cytogenetically normal acute myeloid leukemia (CN-AML) and FLT3ITD.
    Am J Hematol. 2011;86:625-7.
    PubMed     Text format     Related articles   



  33. WIESNER SM , Geurts JL, Diers MD, Bergerson RJ, et al
    Nf1 mutant mice with p19ARF gene loss develop accelerated hematopoietic disease resembling acute leukemia with a variable phenotype.
    Am J Hematol. 2011;86:579-85.
    PubMed     Text format     Related articles    Abstract available



  34. AICHBERGER KJ , Herndlhofer S, Schernthaner GH, Schillinger M, et al
    Progressive peripheral arterial occlusive disease and other vascular events during nilotinib therapy in CML.
    Am J Hematol. 2011;86:533-9.
    PubMed     Text format     Related articles    Abstract available



    June 2011
  35. AUE G , Nelson Lozier J, Tian X, Marie Cullinane A, et al
    Inflammation, TNFalpha and endothelial dysfunction link lenalidomide to venous thrombosis in chronic lymphocytic leukemia.
    Am J Hematol. 2011 Jun 27. doi: 10.1002/ajh.22114.
    PubMed     Text format     Related articles    Abstract available



  36. GAMBACORTI-PASSERINI C , Piazza R
    Choosing the right TKI for chronic myeloid leukemia: When the truth lies in "long-term" safety and efficacy.
    Am J Hematol. 2011 Jun 14. doi: 10.1002/ajh.22084.
    PubMed     Text format     Related articles   



  37. WELCH JS , Klco JM, Gao F, Procknow E, et al
    Combination decitabine, arsenic trioxide, and ascorbic acid for the treatment of myelodysplastic syndrome and acute myeloid leukemia: A phase I study.
    Am J Hematol. 2011 Jun 14. doi: 10.1002/ajh.22092.
    PubMed     Text format     Related articles   



  38. BRECCIA M , Stagno F, Gozzini A, Abruzzese E, et al
    Hammersmith score application identifies chronic myeloid leukemia patients with poor prognosis before treatment with second-generation tyrosine kinase inhibitors.
    Am J Hematol. 2011;86:523-5.
    PubMed     Text format     Related articles   



  39. JEREZ A , Osma Mdel M, Castilla-Llorente C, Bernal A, et al
    Transient bone marrow lymphoproliferation after umbilical cord blood transplantation: exacerbated reconstitution of B-cell ontogeny in adults.
    Am J Hematol. 2011;86:518-20.
    PubMed     Text format     Related articles   



  40. ABDULSALAM AH , Sabeeh N, Bain BJ
    Myeloblasts with unusual morphology.
    Am J Hematol. 2011;86:499.
    PubMed     Text format     Related articles   



    May 2011
  41. FULLMER A , Cortes J, Kantarjian H, Jabbour E, et al
    ASH 2010 meeting report-Top 10 clinically oriented abstracts in acute leukemia.
    Am J Hematol. 2011;86:454-7.
    PubMed     Text format     Related articles   



  42. FULLMER A , Cortes J, Kantarjian H, Jabbour E, et al
    ASH 2010 meeting report-Top 10 clinically oriented abstracts in chronic myeloid leukemia.
    Am J Hematol. 2011;86:450-3.
    PubMed     Text format     Related articles   



  43. CHAUDHRY MS , Macdonald D, Strickland N
    Hairy cell leukemia presenting as a cranial mass.
    Am J Hematol. 2011;86:423-4.
    PubMed     Text format     Related articles   



  44. KRISHNA R , O'Donovan E, Bain BJ
    Neutropenia and anemia with reduced serum vitamin B(12).
    Am J Hematol. 2011;86:417.
    PubMed     Text format     Related articles   



  45. LEE KH , Choi SJ, Lee JH, Lee JH, et al
    Clinical effect of reduced-intensity conditioning regimen containing antithymocyte globulin for hematopoietic cell transplantation from unrelated-donors.
    Am J Hematol. 2011;86:399-405.
    PubMed     Text format     Related articles    Abstract available



  46. PATNAIK MM , Lasho TL, Finke CM, Knudson RA, et al
    Isolated del(5q) in myeloid malignancies: clinicopathologic and molecular features in 143 consecutive patients.
    Am J Hematol. 2011;86:393-8.
    PubMed     Text format     Related articles    Abstract available



    April 2011
  47. BAIN BJ , Heller M
    Dysplastic basophils in the accelerated phase of chronic myelogenous leukemia.
    Am J Hematol. 2011 Apr 19. doi: 10.1002/ajh.22056.
    PubMed     Text format     Related articles   



  48. RIVELL GL , Brunson CY, Milligan L, Stuart RK, et al
    Effectiveness and safety of high-dose cyclophosphamide as salvage therapy for high-risk multiple myeloma and plasma cell leukemia refractory to new biological agents.
    Am J Hematol. 2011 Apr 18. doi: 10.1002/ajh.22054.
    PubMed     Text format     Related articles   



  49. TEFFERI A , Letendre L
    Nilotinib treatment-associated peripheral artery disease and sudden death: Yet another reason to stick to imatinib as front-line therapy for chronic myelogenous leukemia.
    Am J Hematol. 2011 Apr 18. doi: 10.1002/ajh.22051.
    PubMed     Text format     Related articles   



  50. LEE SJ , Jung CW, Kim DY, Lee KH, et al
    Retrospective multicenter study on the development of peripheral lymphocytosis following second-line dasatinib therapy for chronic myeloid leukemia.
    Am J Hematol. 2011;86:346-50.
    PubMed     Text format     Related articles    Abstract available



  51. RAZA S , TaherNazerHussain F, Patnaik M, Knudson R, et al
    Autosomal monosomies among 24,262 consecutive cytogenetic studies: prevalence, chromosomal distribution and clinicopathologic correlates of sole abnormalities.
    Am J Hematol. 2011;86:353-6.
    PubMed     Text format     Related articles    Abstract available



  52. ACKERMANN KA , Z'graggen WJ, El-Koussy M, Caversaccio M, et al
    Blindness in a patient with chronic lymphocytic leukemia.
    Am J Hematol. 2011 Apr 1. doi: 10.1002/ajh.22042.
    PubMed     Text format     Related articles   



    March 2011
  53. DAYYANI F , Mougalian SS, Naqvi K, Shan J, et al
    Prediction model for mortality after intracranial hemorrhage in patients with leukemia.
    Am J Hematol. 2011 Mar 21. doi: 10.1002/ajh.22031.
    PubMed     Text format     Related articles    Abstract available



  54. CLUZEAU T , De Matteis M, Mounier N, Mannone L, et al
    New sequential treatment with chemotherapy and reduced-intensity conditioning for allogeneic stem-cell transplantation in very high-risk acute myeloid leukemia.
    Am J Hematol. 2011 Mar 21. doi: 10.1002/ajh.22029.
    PubMed     Text format     Related articles   



  55. SUDOUR H , Schmitt C, Contet A, Chastagner P, et al
    Acute metabolic encephalopathy in two patients treated with asparaginase and ondasetron.
    Am J Hematol. 2011;86:323-5.
    PubMed     Text format     Related articles   



  56. SUDOUR H , Kimmoun A, Contet A, Clement L, et al
    Successful management with clofarabine for refractory leukaemia in a young adult with chronic renal failure.
    Am J Hematol. 2011;86:321-3.
    PubMed     Text format     Related articles   



  57. PEREIRA A , Nomdedeu M, Aguilar JL, Belkaid M, et al
    Transfusion intensity, not the cumulative red blood cell transfusion burden, determines the prognosis of patients with myelodysplastic syndrome on chronic transfusion support.
    Am J Hematol. 2011;86:245-50.
    PubMed     Text format     Related articles    Abstract available



  58. GERRARD G , Mudge K, Stewart R, Foskett P, et al
    Duplex quantitative PCR for molecular monitoring of BCR-ABL1-associated hematological malignancies.
    Am J Hematol. 2011;86:313-5.
    PubMed     Text format     Related articles   



    February 2011
  59. BAIN BJ
    Dysplastic macropolycytes in myelodysplasia-related acute myeloid leukemia.
    Am J Hematol. 2011 Feb 24. doi: 10.1002/ajh.22018.
    PubMed     Text format     Related articles   



  60. GANESAN P , Sagar TG, Dubashi B, Rajendranath R, et al
    Nonadherence to Imatinib adversely affects event free survival in chronic phase chronic myeloid leukemia.
    Am J Hematol. 2011 Feb 24. doi: 10.1002/ajh.22019.
    PubMed     Text format     Related articles   



  61. GROSICKI S , Holowiecki J, Giebel S, Kyrcz-Krzemien S, et al
    The early reduction of leukemic blasts in bone marrow on day 6 of induction treatment is predictive for complete remission rate and survival in adult acute myeloid leukemia; The results of multicenter, prospective Polish adult leukemia group study.
    Am J Hematol. 2011 Feb 8. doi: 10.1002/ajh.21996.
    PubMed     Text format     Related articles   



  62. YANG H , Fang Z, Wei Y, Hu Y, et al
    Levels of miR-29b do not predict for response in patients with acute myelogenous leukemia treated with the combination of 5-azacytidine, valproic acid, and ATRA.
    Am J Hematol. 2011;86:237-8.
    PubMed     Text format     Related articles   



  63. MAITTA RW , Wolgast LR, Wang Q, Zhang H, et al
    Alpha- and beta-synucleins are new diagnostic tools for acute erythroid leukemia and acute megakaryoblastic leukemia.
    Am J Hematol. 2011;86:230-4.
    PubMed     Text format     Related articles   



  64. DAUGUET N , Recher C, Demur C, Fournie JJ, et al
    Pre-eminence and persistence of immature natural killer cells in acute myeloid leukemia patients in first complete remission.
    Am J Hematol. 2011;86:209-13.
    PubMed     Text format     Related articles    Abstract available



  65. MARTIN-BABAU J , Tempescul A, Moreau L, Staroz F, et al
    Relapsing acute myeloid leukemia beginning with a penile localization.
    Am J Hematol. 2011;86:193-4.
    PubMed     Text format     Related articles   



  66. SCHWARB H , May PC, Apperley J, Naresh KN, et al
    Bone marrow trephine biopsy findings in B acute lymphoblastic leukaemia of early precursor (Pro-B) subtype.
    Am J Hematol. 2011;86:195-6.
    PubMed     Text format     Related articles   



    January 2011
  67. HASHIM ABDULSALAM A , Sabeeh N, Bain BJ
    Pseudo-Chediak-Higashi inclusions together with Auer rods in acute myeloid leukemia.
    Am J Hematol. 2011 Jan 5. doi: 10.1002/ajh.21973.
    PubMed     Text format     Related articles   



  68. CROWLEY LC , Elzinga BM, O'Sullivan GC, McKenna SL, et al
    Autophagy induction by Bcr-Abl-expressing cells facilitates their recovery from a targeted or nontargeted treatment.
    Am J Hematol. 2011;86:38-47.
    PubMed     Text format     Related articles    Abstract available



  69. YOO KH , Lee SH, Sung KW, Koo HH, et al
    Current status of pediatric umbilical cord blood transplantation in Korea: a multicenter retrospective analysis of 236 cases.
    Am J Hematol. 2011;86:12-7.
    PubMed     Text format     Related articles    Abstract available



    December 2010
  70. CAO F , Amato D, Wang C
    Concurrent chronic lymphocytic leukemia and prolymphocytic leukemia derived from two separate B-cell clones.
    Am J Hematol. 2010 Dec 22. doi: 10.1002/ajh.21970.
    PubMed     Text format     Related articles   



  71. ROPER N , DeAngelo DJ, Kuo F, Dal Cin P, et al
    An asymptomatic 61-year-old man with BCR-ABL-positive bone marrow following autologous transplantation for multiple myeloma.
    Am J Hematol. 2010;85:944-6.
    PubMed     Text format     Related articles   



    November 2010
  72. ZACKOVA D , Klamova H, Dusek L, Muzik J, et al
    Imatinib as the first-line treatment of patients with chronic myeloid leukemia diagnosed in the chronic phase: Can we compare real life data to the results from clinical trials?
    Am J Hematol. 2010 Nov 29. doi: 10.1002/ajh.21942.
    PubMed     Text format     Related articles   



  73. WISEMAN DH , Das M, Poulton K, Liakopoulou E, et al
    Donor cell leukemia following unrelated donor bone marrow transplantation for primary granulocytic sarcoma of the small intestine.
    Am J Hematol. 2010 Nov 22. doi: 10.1002/ajh.21938.
    PubMed     Text format     Related articles   



    October 2010
  74. GERBER JM , Qin L, Kowalski J, Smith BD, et al
    Characterization of chronic myeloid leukemia stem cells.
    Am J Hematol. 2010.
    PubMed     Text format     Related articles    Abstract available



  75. DAUGUET N , Recher C, Demur C, Fournie JJ, et al
    Pre-eminence and persistence of immature natural killer cells in acute myeloid leukemia patients in first complete remission.
    Am J Hematol. 2010.
    PubMed     Text format     Related articles    Abstract available



  76. YOON SO , Suh C, Lee DH, Chi HS, et al
    Distribution of lymphoid neoplasms in the Republic of Korea: analysis of 5318 cases according to the World Health Organization classification.
    Am J Hematol. 2010;85:760-4.
    PubMed     Text format     Related articles    Abstract available



    September 2010
  77. VAGACE JM , Caceres-Marzal C, Jimenez M, Casado MS, et al
    Methotrexate-induced subacute neurotoxicity in a child with acute lymphoblastic leukemia carrying genetic polymorphisms related to folate homeostasis.
    Am J Hematol. 2010.
    PubMed     Text format     Related articles   



  78. DVORAKOVA D , Racil Z, Jeziskova I, Palasek I, et al
    Monitoring of minimal residual disease in acute myeloid leukemia with frequent and rare patient-specific NPM1 mutations.
    Am J Hematol. 2010.
    PubMed     Text format     Related articles    Abstract available



  79. SINGH H , Werner L, Deangelo D, Ballen K, et al
    Clinical outcome of patients with acute promyelocytic leukemia and FLT3 mutations.
    Am J Hematol. 2010.
    PubMed     Text format     Related articles   



  80. VISANI G , Breccia M, Gozzini A, Specchia G, et al
    Dasatinib, even at low doses, is an effective second-line therapy for chronic myeloid leukemia patients resistant or intolerant to imatinib. Results from a real life-based Italian multicenter retrospective study on 114 patients.
    Am J Hematol. 2010.
    PubMed     Text format     Related articles   



  81. ROCQUAIN J , Gelsi-Boyer V, Adelaide J, Murati A, et al
    Alteration of cohesin genes in myeloid diseases.
    Am J Hematol. 2010;85:717-9.
    PubMed     Text format     Related articles    Abstract available



  82. BAIN BJ
    Neutrophil dysplasia demonstrated on Sudan black B staining.
    Am J Hematol. 2010;85:707.
    PubMed     Text format     Related articles   



    August 2010
  83. LUTHERBORROW M , Bryant A, Jayaswal V, Agapiou D, et al
    Expression profiling of cytogenetically normal acute myeloid leukemia identifies MicroRNAs that target genes involved in monocytic differentiation.
    Am J Hematol. 2010.
    PubMed     Text format     Related articles    Abstract available



  84. KIM DH , Sriharsha L, Jung CW, Kamel-Reid S, et al
    Comprehensive evaluation of time-to-response parameter as a predictor of treatment failure following imatinib therapy in chronic phase chronic myeloid leukemia: Which parameter at which time-point does matter?
    Am J Hematol. 2010.
    PubMed     Text format     Related articles    Abstract available



  85. KOHRT HE , Patel S, Ho M, Owen T, et al
    Second-line mitoxantrone, etoposide, and cytarabine for acute myeloid leukemia: A single-center experience.
    Am J Hematol. 2010.
    PubMed     Text format     Related articles    Abstract available



  86. FREZZATO M , Giaretta I, Madeo D, Rodeghiero F, et al
    Identical IGHV-D-J gene rearrangement may precede the clinical onset of chronic lymphocytic leukemia by several years.
    Am J Hematol. 2010.
    PubMed     Text format     Related articles    Abstract available



  87. NARESH KN , Pavlu J
    Plasmacytoid dendritic cell nodules in bone marrow biopsies of chronic myelomonocytic leukemia.
    Am J Hematol. 2010.
    PubMed     Text format     Related articles   



  88. PAPAYANNIDIS C , Iacobucci I, Abbenante MC, Curti A, et al
    Complete paraplegia after Nelarabine treatment in a T-cell acute lymphoblastic leukemia adult patient.
    Am J Hematol. 2010;85:608.
    PubMed     Text format     Related articles   



  89. ARREDONDO AR , Gotlib J, Shier L, Medeiros B, et al
    Myelomastocytic leukemia versus mast cell leukemia versus systemic mastocytosis associated with acute myeloid leukemia: a diagnostic challenge.
    Am J Hematol. 2010;85:600-6.
    PubMed     Text format     Related articles   



  90. PICCIN A , Cortelazzo S, Rovigatti U, Bourke B, et al
    Immunosuppressive treatments in Crohn's disease induce myelodysplasia and leukaemia.
    Am J Hematol. 2010;85:634.
    PubMed     Text format     Related articles   



  91. DESMOND R , Lynch K, Gleeson M, Farrell M, et al
    Progressive multifocal leukencephalopathy and cerebral toxoplasmosis in a patient with CLL.
    Am J Hematol. 2010;85:607.
    PubMed     Text format     Related articles   



    July 2010
  92. RANADE A , Selegean S, Sandhu G, Ghali V, et al
    Acute lymphoblastic leukemia in a patient with type 1 Gaucher disease developing 1 year after discontinuation of enzyme replacement therapy.
    Am J Hematol. 2010.
    PubMed     Text format     Related articles   



  93. MARTIN-BABAU J , Tempescul A, Moreau L, Staroz F, et al
    Relapsing acute myeloid leukemia beginning with a penile localization.
    Am J Hematol. 2010.
    PubMed     Text format     Related articles   



  94. ZHENG C , Liu X, Wu J, Cai X, et al
    Which steroids should we choose for the treatment of adult acute lymphoblastic leukemia?
    Am J Hematol. 2010.
    PubMed     Text format     Related articles   



  95. ZANOTTI R , Frattini F, Ghia P, Visco C, et al
    ZAP-70 expression is associated with increased risk of autoimmune cytopenias in CLL patients.
    Am J Hematol. 2010;85:494-8.
    PubMed     Text format     Related articles    Abstract available



    June 2010
  96. PARAJULI R , Altman J, Kuzel T, Perdekamp M, et al
    Renal cell carcinoma and acute promyelocytic leukemia: A nonrandom association?
    Am J Hematol. 2010.
    PubMed     Text format     Related articles   



  97. CHEN CC , Weng HH, Hwang CE, Lu CH, et al
    Acute leukemia presenting with extramedullary diseases and completely normal hemogram: An extremely unusual manifestation unique to pre-B ALL.
    Am J Hematol. 2010.
    PubMed     Text format     Related articles   



  98. LIBBY E , Candelaria-Quintana D, Moualla H, Abdul-Jaleel M, et al
    Durable complete remission of primary plasma cell leukemia with the bortezomib plus melphalan and prednisone (VMP) regimen.
    Am J Hematol. 2010.
    PubMed     Text format     Related articles   



  99. FERRARA F , Izzo T, Criscuolo C, Riccardi C, et al
    Day 15 bone marrow driven double induction in young adult patients with acute myeloid leukemia: Feasibility, toxicity, and therapeutic results.
    Am J Hematol. 2010.
    PubMed     Text format     Related articles    Abstract available



  100. HAMMOND SP , Marty FM, Bryar JM, Deangelo DJ, et al
    Invasive fungal disease in patients treated for newly diagnosed acute leukemia.
    Am J Hematol. 2010.
    PubMed     Text format     Related articles    Abstract available



    March 2010
  101. NARESH KN , Marks AJ
    Peripheral blood and bone marrow morphology in adult T-cell leukaemia/lymphoma.
    Am J Hematol. 2010;85:518.
    PubMed     Text format     Related articles   



Thank you for your interest in scientific medicine.


Amedeo is a Flying Publisher website.

   Design: